USSTOCK.TODAY
Regular Market
Log in Sign up

Hims & Hers Health Launches 5 Peptide and Longevity Formulations

CNBC · ·by G4L

  1. 1Hims & Hers Health announced it is offering five compounded peptide and longevity treatments in the U.S.
  2. 2More than 10,000 people registered on the Hims early access list within 15 days.
  3. 3The FDA stated it received reports of at least 30 patients experiencing adverse reactions after taking compounded IV glutathione in August.

So what's the key point?

Hims & Hers Health has introduced new wellness medications. While early registrations exceeded 10,000, reports have also been made regarding patients experiencing adverse reactions after taking the medication.

Source CNBC · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →